concerned with economics, and thus may be used as a stick with which to beat the clinician who is endeavouring to do the best for his patient as distinct from making his primary aim the containment of cost. (3) Of most philosophical importance, to me, is the fact that externally agreed norms derived from the analysis of process will inevitably lead to regression towards a mean, and this mean may be below that to which we would all wish to aspire; such would be particularly the case if the norm was used by some official body to determine not only the lower but also the upper limits of resources which were to be made available.
I make these observations for a specific reason.
Process orientation is very popular in other parts of the world and has been worked up into an effective weapon. There is a considerable risk that it could be introduced into this country from outside the profession, particularly if we leave a vacuum by failing to launch appropriate audit procedures ourselves. Therefore it is important to us all to be highly and objectively self-analytical, to pursue the most appropriate framework for self-assessment and rapidly to bring in careful audit in relation to outcome which may then lead to more logical application of resources where these are truly needed. unacceptable or poor performance on occasions; thus it is essential that the procedures used to identify persistent offenders should have a sound scientific basis and be acceptable to participants.
A system of depicting long-term performance has been devised by the NQCS in clinical chemistry. This system allocates a score for each assay performed in the scheme, determined by the difference of the result from the mean of all results obtained by a specific method. The scores obtained for different assays are averaged to produce a running score termed the 'variance index'. In 1973 when approximately 40G laboratories were participating in the NQCS, limits of variance index were specified which included 90 % of all participants; 10% were excluded, 5% as 'good' performers and 5 % as 'poor' performers. Fig 1 illustrates the record of a laboratory (Lab. A) with persistently good performance and of a poor laboratory (Lab. B) which has achieved considerable improvement. Since the designation of the limits of the 90 percentile in 1973 they have not been modified. The persistent offender or poor performer could be defined as a laboratory with a variance index consistently in the 5 percentile of poor performers. The number of laboratories that have maintained a variance index consistently in the 5 percentile of poor performers has not been disclosed. However, the existence of evidence such as that illustrated in Fig 1 demands that the problem of treatment of poor performers must be considered.
If treatment of the persistent offender is to be effective then the reasons for poor performance must be known. Only when this information is available will it be possible to provide help and advice to poor laboratories.
Certain provocative measures have been advocated to reduce the number of laboratories that persistently perform badly in quality control schemes. These measures include: (1) Compulsory participation in quality control schemes.
(2) Abandonment of anonymity in quality control schemes.
(3) Provision of information to Regional Health Authorities regarding poor performance by laboratories in their region. (4) Closure of laboratories or replacement oflaboratory directors in the event that performance does not improve.
These measures have been adopted in principle in certain countries.
There is little doubt that the criteria of assessment must differ between the disciplines in pathology. The function of the clinical chemist's work, with its major commitment to the production of numerical data, often using automated equipment, is quite different from the subjective assessment of a tissue section by the histopathologist. At the same time, there can be no justification for lack of concern when surveys demonstrate wide LAB NO. Many pathologists believe that the identification of the problem areas, coupled with an active programme of education, is sufficient action and hope that a poor performer will respond to this and that improvement in standards will follow. As education and identification ofproblems should be within the scope of professional activity, some believe that the presence of the Department of Health or other official agencies in this area is both unnecessary and undesirable. It is partly for this reason that anonymous participation in quality control schemes is advocated.
The scheme operated by the Department of Health ensures anonymity for its participants. However, pathologists must recognize that if schemes currently in operation unequivocally establish that laboratories in this country operate at a standard which might prejudice the care of patients, then the argument for the provocative measures listed earlier gains strength.
Monitoring of poor performers and treatment of persistent offenders could be provided by various organizations: (1) Advantages could ensue from all of these bodies carrying out monitoring activities. The international bodies would undoubtedly be suited towards bringing about the ultimate goal of standardization of methods or interpretation. The Department of Health might influence appointments or expenditure to benefit laboratories in need. However, it is suggested that in the United Kingdom the professions may be the most suitable media. All the professional bodies listed above, with the exception of the ACP, award higher qualifications. These qualifications are dependent on training in approved establishments and the professional bodies are thus in a position to exert their influence. If the professions are to participate in the monitoring of laboratory performance, then it is conceivable that many of those who oppose abandonment of anonymity might accept schemes based on confidentiality, where results or performance are considered only by professional bodies.
The mechanism by which professional bodies might participate in the monitoring or training of poor performance is currently under discussion, but most pathologists realize that any scheme which alienates the profession or encourages withdrawal from schemes would fail at the outset.
The obvious conclusion is to establish panels representing the professions which are acceptable to laboratory directors. These panels could provide advice or could influence the employing authority to deploy manpower or equipment.
Knowledge of the factors causing poor laboratory performance is obviously a prerequisite for the provision of advice in this area. The causes probably include direction, staff, facilities, equipment, expertise; of these direction and expertise are probably of greatest importance. Certainly the NQCS in clinical chemistry has illustrated that the size of a laboratory, its equipment and facilities are not the only route to successful laboratory performance. The implications of training of the poor performers are obvious. Training will be necessary on occasions, although the need will be reduced if educational programmes are successful. If laboratory directors accept their own fallibility, the abandonment of anonymity is not a hurdle, particularly when replaced by confidentiality. The professions can influence the rate of improvement of standards by education, and by insistence on a demonstration of performance by training centres or laboratories. Today's problem may be the treatment of laboratories that persistently perform blood urea determinations to an unsatisfactory standard; if this problem is rapidly solved, there will, inevitably, be a continuing field of activity when the need to develop and control expertise in new assay procedures is encountered. 
